Top Videos
Top Searches
Shuren Fda
What is CDRH doing to accelerate the regulatory pathway for innovative medical technologies?
6:16
|
Jeffrey Shuren, director of FDA's CDRH will make end year (2011) announcement on amalgam rule
4:36
|
EP. 2 Jeffrey Shuren on FDA-sponsor interactions: Where they’ve been and where they’re going
29:01
|
Did FDA's Jeffrey Shuren lie under oath about Google-backed 23andMe?
4:58
|
Jeff Shuren of the FDA at the 2023 Utah Life Sciences Summit
45:24
|
CDRH Center Director Jeff Shuren on why FDA invests in MDIC
0:56
|
Reporting on MassMEDIC's Regulatory Roundup
7:32
|
US FDA CDRH Director Jeff Shuren presents at the MDIC 2015 Annual Public Forum
10:51
|
FDA official testifies regarding laboratory developed tests (LDTs)
4:02
|
MDUFA IV and Beyond: Video Reports
9:24
|
Interview with Director of the FDA's CDRH medical device division, Dr. Shuren
8:51
|
What's most important for innovators to understand about FDA's new mobile health guideline?
3:01
|
What's going on with the harmonization of regulatory standards across geographies?
3:51
|
Conversation with Dr. Jeff Shuren
48:09
|
CDRH Center Director Jeff Shuren on MDIC's Patient Preference Framework
1:11
|
FDA Roundtable
48:31
|
Safety Signal Transparency: Using the Power of Data
34:48
|
07/18/2018 - Session VI: Shuren
13:41
|
FDA Town Hall from the 2024 Utah Life Sciences Summit
44:23
|
Closing Keynote: CDRH Updates
28:50
|
← Previous
12
Next →